Testing simvastatin and hyaluronic acid gel to help dental implants heal and enhance their stability

ISRCTN ISRCTN14814823
DOI https://doi.org/10.1186/ISRCTN14814823
Submission date
13/05/2025
Registration date
16/05/2025
Last edited
27/08/2025
Recruitment status
Recruiting
Overall study status
Ongoing
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
This study is looking at ways to help dental implants heal better and stay in place more securely. Researchers are testing whether applying hyaluronic acid gel (a substance naturally found in the body) and simvastatin (a common medicine used to lower cholesterol) at the implant site can improve healing and stability.

Who can participate?
People who need dental implants and meet certain health criteria may be able to take part. Some individuals, such as those with certain medical conditions or habits like smoking, may not be eligible.

What does the study involve? (for participants)
A total of 32 participants will be divided into four groups:
-One group will receive no special treatment (control group).
-One group will have hyaluronic acid gel applied to the implant site.
-One group will receive simvastatin.
-One group will get both hyaluronic acid and simvastatin.
Researchers will check how stable the implants are right after placement, then again at 40 days and 60 days.

What are the possible benefits and risks of participating?
Participants may benefit from improved healing of their dental implants. However, as with any medical study, there may be some risks, such as side effects or reactions to the treatments. All participants will be monitored closely.

Where is the study run from?
University of Suleimani (Iraq)

When is the study starting and how long is it expected to run for?
July 2024 to September 2025

Who is funding the study?
Investigator initiated and funded

Who is the main contact?
Dr Ahmed Mohammed, ahmed.darweesh@univsul.edu.iq

Contact information

Dr Ahmed Mohammed
Public, Scientific, Principal Investigator

Al-Shorja Street
Kirkuk
36001
Iraq

ORCiD logoORCID ID 0009-0008-2759-5610
Phone +964 7701688495
Email ahmed.darweesh@univsul.edu.iq

Study information

Study designProspective interventional randomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)University/medical school/dental school
Study typeEfficacy
Participant information sheet 47326 PIS (Arabic).pdf
Scientific titleEvaluation of the effect of hyaluronic acid gel and simvastatin on dental implant stability
Study objectivesThe null hypothesis to be tested is:
The application of hyaluronic acid gel and simvastatin does not result in a statistically significant improvement in bone regeneration and implant stability compared to the use of either agent alone or conventional methods.
Ethics approval(s)

Approved 16/12/2024, Ethical Committee of the College of Dentistry, University of Sulaimani (College of Dentistry, University of Sulaimani, Madam Mitterrand street, As Sulaymaniyah, Iraq, Sulaymaniyah, 46001, Iraq; +964 7704522890; dentistry.ethics@univsul.edu.iq), ref: COD-EC-24-0048

Health condition(s) or problem(s) studiedPromoting dental implant stability in edentulous adults
InterventionThis is a randomized, controlled clinical trial including 32 dental implants placed in medically healthy adult patients (18–60 years old), divided equally into four groups (n = 8 implants/group).

Group 1 – Control Group
Treatment: No adjunctive material.
Administration: Standard implant placement following conventional osteotomy preparation.
Duration: Implant placed at baseline.
Follow-up: ISQ measured immediately post-op, at 40 days, and at 60 days.
Total Follow-up: 60 days.

Group 2 – Hyaluronic Acid (HA) Group
Treatment: Hyaluronic acid gel.
Dose: 0.1 ml of hyaluronic acid gel per osteotomy site.
Administration: HA gel is injected directly into the osteotomy site before implant placement.
Duration: Single administration at baseline.
Follow-up: ISQ measured at baseline, 40 days, and 60 days.
Total Follow-up: 60 days.

Group 3 – Simvastatin Gel Group
Treatment: Simvastatin prepared in gel form.
Dose: 0.1 ml of simvastatin gel per osteotomy site.
Administration: The gel is inserted into the osteotomy site just before implant placement.
Duration: Single administration at baseline.
Follow-up: ISQ measured at baseline, 40 days, and 60 days.
Total Follow-up: 60 days.

Group 4 – Combination Group (Simvastatin + Hyaluronic Acid)
Treatment: A mixture of simvastatin gel and hyaluronic acid gel.
Dose: 0.1 ml of the combined gel (containing both agents) per osteotomy site.
Administration: The mixture is inserted into the osteotomy site immediately before implant placement.
Duration: Single administration at baseline.
Follow-up: ISQ measured at baseline, 40 days, and 60 days.
Total Follow-up: 60 days.

Randomization Process
Patients are randomly allocated to one of the four groups using a sealed opaque envelope technique. Allocation is performed by an independent third party to ensure allocation concealment and reduce selection bias.
Intervention typeOther
Primary outcome measureImplant Stability Quotient (ISQ) values measured at three time points (immediate, 40 days, and 60 days post-implantation) using resonance frequency analysis.
Secondary outcome measuresThere are no secondary outcome measures
Overall study start date05/07/2024
Completion date30/09/2025

Eligibility

Participant type(s)Healthy volunteer, Patient
Age groupAdult
Lower age limit18 Years
Upper age limit60 Years
SexBoth
Target number of participants32 dental implants
Key inclusion criteria1. Patients aged 18–60 years with missing teeth.
2. Systemically healthy individuals.
3. Patients with bone density D3 at the site of implant placement.
4. Presence of adequate bone height minimum of 10 mm above the anatomical landmarks and adequate width, so that 1.5–2 mm of bone is present all around the implants after implant placement.
5. Bone crest healing period of more than 3 months before implant placement.
6. Good oral hygiene and compliance with follow-up appointments.
7. No known allergies to simvastatin or hyaluronic acid.
Key exclusion criteria1. Patients with uncontrolled systemic diseases.
2. Patients who are chronic smokers.
3. Pregnant and lactating women.
4. Patients with a history of chemotherapy or radiotherapy in the last 6 months.
5. Patients with blood dyscrasias.
6. Patients with parafunctional habits like bruxism.
7. Patients with poor oral hygiene and untreated periodontal disease.
8. Patients with a history of allergy to SMV or HA.
9. Alcoholic patients or alcohol users.
10. Patients with active liver disease and those on Warfarin and/or antifungal medication.
Date of first enrolment10/01/2025
Date of final enrolment30/09/2025

Locations

Countries of recruitment

  • Iraq

Study participating centre

University of Suleimani
College of Dentistry, Madam Mitterrand street
Sulaymaniyah
46001
Iraq

Sponsor information

University of Sulaimani
University/education

College of Dentistry, Madam Mitterrand, Sulaymaniyah, Iraq
Sulaymaniyah
46001
Iraq

Phone +964 7725447528
Email pg.dent@univsul.edu.iq
Website https://dent.univsul.edu.iq
ROR logo "ROR" https://ror.org/00saanr69

Funders

Funder type

Other

Investigator initiated and funded

No information available

Results and Publications

Intention to publish date01/02/2026
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a peer-reviewed journal
IPD sharing planAt the end of the study, anonymized individual participant data (IPD) may be shared upon reasonable request for research or academic purposes. Data will be de-identified to protect participant privacy and confidentiality. Requests must be submitted to the chief investigator and approved by the ethics committee. The data will only be shared under a data-sharing agreement that ensures proper use.
contact info;
Name: AHMED JAMEEL MOHAMMED DARWEESH
Email: ahmed.darweesh@univsul.edu.iq

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet in Arabic 15/05/2025 No Yes
Participant information sheet in English 15/05/2025 No Yes
Participant information sheet in Kurdish 15/05/2025 No Yes

Additional files

47326 PIS (English).pdf
in English
47326 PIS (Arabic).pdf
in Arabic
47326 PIS (Kurdish).pdf
in Kurdish

Editorial Notes

27/08/2025: The date of final enrolment and the completion date were changed from 31/07/2025 to 30/09/2025.
13/05/2025: Trial's existence confirmed by the Ethical Committee of the College of Dentistry, University of Sulaimani.